Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Next Phase In Oncology: FDA’s Pazdur Has New Vision For Drug Development

11 Nov 2013

• By Ramsey Baghdadi and Mary Jo Laffler

Related Content

Accelerated And Accompanied: Oncology Drugs Should Use Randomized Trials, FDA Panel Says

08 Feb 2011

Swing for the Fences: FDA's Top Cancer Drug Official Urges "Home Run" Trial Designs for Targeted Therapies

01 Jan 2011

Can <em>Iclusig</em> Return To Market? Ariad Sees Path Through Restricted Distribution REMS

04 Nov 2013

Related Companies

Bayer AG

Pfizer Inc.

ARIAD Pharmaceuticals, Inc.

Additional Topics

Clinical Trials Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.